- Health & Pharmaceuticals›
- State of Health›
Impact of medicines on life expectancy for select rare diseases worldwide as of 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Impact of medicines on life expectancy for select rare diseases worldwide as of 2017
Life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017
by John Elflein,
last edited
Jul 25, 2018
This statistic shows the life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017. Before the current available treatment an individual with cystic fibrosis could expect to live less than one year. Now, however, the life expectancy of an individual with cystic fibrosis with current treatment is 37 years.
Life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017
| Before available treatment | Now | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| Before available treatment | Now | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by John Elflein,
last edited
Jul 25, 2018
This statistic shows the life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017. Before the current available treatment an individual with cystic fibrosis could expect to live less than one year. Now, however, the life expectancy of an individual with cystic fibrosis with current treatment is 37 years.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- February 2017
- Region
- Worldwide
- Survey time period
- as of 2017
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- February 2017
More information
- Region
- Worldwide
- Survey time period
- as of 2017
Other statistics on the topic
Orphan drugs
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Market share of top 20 companies for orphan drugs worldwide 2018 and 2024
Pharmaceutical Products & Market
Price comparison of the 10 most expensive drugs as of 2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Orphan drugs
- 56 page/s
- English
- pptx
- Detailed references
Everything On "Orphan drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Orphan drugs"
- Market overview
The most important statistics
- Global prescription orphan drug sales from 2010 to 2024 (in billion U.S. dollars)Projection of global revenue for orphan prescription drugs 2010-2024
- Global prescription orphan drug annual growth in revenues from 2011 to 2024Annual growth in global revenue for prescribed orphan drugs 2011-2024
- Average annual cost of orphan drugs per patient from 2014 to 2018 (in U.S. dollars)*Annual average cost of orphan drugs per patient 2014-2018
- Per-year list price of the top ten most expensive drugs worldwide as of 2018*Price comparison of the 10 most expensive drugs as of 2018
- Median cost per patient per year for orphan and non-orphan drugs from 2014 to 2018 (in U.S. dollars)Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Companies
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top pharmaceutical companies by orphan drug revenue worldwide in 2018 (in billion U.S. dollars)Top global companies by orphan drug revenues 2018
- Forecast of top 10 pharmaceutical companies by global orphan drug revenue in 2024 (in billion U.S. dollars)*Top 10 companies by global revenue from orphan drugs 2024
- Top 20 pharmaceutical companies worldwide by orphan drug revenue market share in 2024 compared to 2018*Market share of top 20 companies for orphan drugs worldwide 2018 and 2024
- Products
The most important statistics
- Top global orphan drugs by revenue in 2018 (in billion U.S. dollars)*Top global orphan drugs by revenue 2018
- Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*Projection of top 10 orphan drugs by global revenue 2024
- Annual number of accepted orphan designations in the United States from 2003 to 2018Number of orphan designations accepted in the U.S. 2003-2018
- Percentage of select orphan drugs' U.S. revenues attributable to non-orphan usage in 2017Percentage of select orphan drug US sales by non/orphan use 2017
- Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018FDA approved orphan drugs with non-orphan indications 1983-2018
- Research and development
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Projection of top 10 orphan drugs in development (phase III/filed) by NPV as of 2019 (in billion U.S. dollars)Leading orphan drugs in development based on net present value 2019
- Number of non-oncology orphan designated products currently being developed worldwide by company type as of April 2019Global therapeutic pipeline for non-oncology orphan drug programs by company 2019
- Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current statusTime from orphan drug design to final exclusivity 2018, by current status
- Probability of success for new rare disease and high prevalence disease drugs in the U.S. by development phase from 2006 to 2015U.S. development Phase success rates for rare and common disease drugs 2006-2015
- Rare diseases
The most important statistics
- Number of rare diseases, disease patients and treatments worldwide and in the U.S. as of 2016Overview of rare diseases worldwide and in the U.S. as of 2016
- Life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017Impact of medicines on life expectancy for select rare diseases worldwide as of 2017
- Distribution of patients in the U.S. with rare factor deficiencies as of 2018, by gender* Distribution of U.S. patients with rare factor deficiencies as of 2018, by gender
- Feelings of patients with rare diseases in the U.S. compared to other patients as of 2015U.S. rare disease patient feelings as of 2015
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Overview of rare diseases worldwide and in the U.S. as of 2016
- Share of primary Sjögren's patients in the U.S. and EU with impairments 2011-2013
- Total rare diseases funding by the National Institutes for Health 2013-2020
- Share of primary Sjögren patients in the U.S. and EU using healthcare resources 2013
- Comorbidity in primary Sjögren's patients in the U.S. and EU 2015
- Italy: number of rare disease projects funded by the Telethon Foundation 2012-2016
- Italy: value of rare disease projects funded by the Telethon Foundation 2011-2017
- Italy: rare disease patients treated within clinical trials 2017, by disease
- Opinion of the French on the effectiveness of drugs against mental illnesses 2014
- Privileged interlocutors to talk about his mental health in France 2014
- Italy: share of clinical trials for rare diseases 2013-2017
- Top rare disease therapeutic companies enterprise value worldwide 2000-2017
- Italy: expenditure on orphan drugs 2017, by ATC
- Prevalence of selected rare diseases worldwide 2017
- Health: Weekly household expenditure in the United Kingdom (UK) 2017/18 by age
- Personal health perceptions on needed medical care in China 2018
- Industry revenue of “Manufacture of herb medicaments“ in South Korea 2011-2023
- Prescription per capita in the United States by age group 2013
- Number of Canadian laboratory medicine specialists 2018, by area
Studies
- Bleeding disorders in the U.S.
- World Federation of Hemophilia Report on the Annual Global Survey 2017
- World Federation of Hemophilia Report on the Annual Global Survey 2016
- Annual Asthma Survey 2018 report
- World Federation of Hemophilia Report on the Annual Global Survey 2013
- World Federation of Hemophilia Report on the Annual Global Survey 2014
- World Federation of Hemophilia Report on the Annual Global Survey 2015
- Tackling drug-resistant infections globally: the review on antimicrobial resistance
Statistics on "Orphan drugs"
- Global prescription orphan drug sales from 2010 to 2024 (in billion U.S. dollars)
- Global prescription orphan drug annual growth in revenues from 2011 to 2024
- Average annual cost of orphan drugs per patient from 2014 to 2018 (in U.S. dollars)*
- Per-year list price of the top ten most expensive drugs worldwide as of 2018*
- Median cost per patient per year for orphan and non-orphan drugs from 2014 to 2018 (in U.S. dollars)
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- Top pharmaceutical companies by orphan drug revenue worldwide in 2018 (in billion U.S. dollars)
- Forecast of top 10 pharmaceutical companies by global orphan drug revenue in 2024 (in billion U.S. dollars)*
- Top 20 pharmaceutical companies worldwide by orphan drug revenue market share in 2024 compared to 2018*
- Top global orphan drugs by revenue in 2018 (in billion U.S. dollars)*
- Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*
- Annual number of accepted orphan designations in the United States from 2003 to 2018
- Percentage of select orphan drugs' U.S. revenues attributable to non-orphan usage in 2017
- Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Projection of top 10 orphan drugs in development (phase III/filed) by NPV as of 2019 (in billion U.S. dollars)
- Number of non-oncology orphan designated products currently being developed worldwide by company type as of April 2019
- Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status
- Probability of success for new rare disease and high prevalence disease drugs in the U.S. by development phase from 2006 to 2015
- Number of rare diseases, disease patients and treatments worldwide and in the U.S. as of 2016
- Life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017
- Distribution of patients in the U.S. with rare factor deficiencies as of 2018, by gender*
- Feelings of patients with rare diseases in the U.S. compared to other patients as of 2015
- Patients with Sjögren syndrome experiencing impairments in the U.S. and the EU between 2011 and 2013
- Total rare diseases funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)
- Patients with Sjögren syndrome using healthcare resources in the U.S. and the EU between 2011 and 2013*
- Prevalence of comorbidities among Sjögren syndrome patients in the U.S. and the EU as of 2015
- Number of projects on rare diseases financed by the Telethon Foundation in Italy from 2012 to 2016
- Economic value of projects on rare diseases financed by the Telethon Foundation in Italy from 2011 to 2017 (in million euros)
- Number of rare disease patients treated within clinical trials funded by the Telethon Foundation in Italy in 2017, by disease
- How do you rate the effectiveness of medications for mental illness?
- If you ever had any doubts or questions about your mental health, who would you talk to?
- Share of authorized clinical trials to treat rare diseases in Italy from 2013 to 2017*
- Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)*
- Distribution of orphan drugs expenditure in Italy in 2017, by ATC*
- Prevalence rate of selected rare diseases worldwide as of 2017 (per 100,000 population)*
- Average weekly household expenditure on health in the United Kingdom (UK) in 2017/18, by age of household reference person* (in GBP)
- Share of people who think that they get all the medical care that is needed in China in 2018
- Industry revenue of “Manufacture of herb medicaments“ in South Korea from 2011 to 2023 (in billion U.S. Dollars)
- Prescriptions per capita in the U.S. in 2013, by age group*
- Number of laboratory medicine specialists in Canada as of 2018, by area
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.